Integrating Artificial Intelligence Into Telemedicine: Evidence, Challenges, and Future Directions.

Telemedicine has revolutionized healthcare by enabling remote diagnosis, monitoring, and treatment. However, challenges such as clinician workload, data variability, and technological disparities hinder its full potential. Artificial intelligence (AI) offers solutions by automating diagnostics, predictive analytics, and real-time monitoring, yet its integration into telemedicine presents ethical, regulatory, and implementation challenges. This review explores the role of AI in telemedicine, identifying key applications, challenges, and future directions. A systematic literature search was conducted in PubMed and the Cochrane Library, covering the period from 2015 to 2024, adhering to PRISMA guidelines. Of the 40 identified articles, 31 met the inclusion criteria for thematic evaluation. Relevant studies were selected based on predefined criteria, and thematic evaluation identified trends, barriers, and innovations in AI-driven telemedicine. AI has been successfully implemented in diverse telemedicine applications. In dermatology, AI-driven image analysis achieves diagnostic accuracy comparable to experts. Ophthalmology benefits from AI-enhanced screening for diabetic retinopathy and glaucoma. AI-powered chatbots and digital assistants improve mental health support and patient triage. Wearable devices utilizing AI facilitate continuous monitoring of cardiovascular and respiratory conditions. Emerging technologies such as blockchain-based digital pathology and decentralized AI models have been proposed, and in some cases demonstrated in proof-of-concept studies, to enhance data protection and accessibility in telemedicine. However, challenges persist, including algorithmic bias, data privacy concerns, regulatory inconsistencies, and limited real-world validation of AI models. Overall, evidence from multiple specialties indicates that AI can enhance telemedicine by improving diagnostic accuracy, patient monitoring, and remote healthcare delivery. However, the degree of benefit varies across clinical domains, and most studies remain limited in real-world validation. Moreover, ethical considerations, regulatory compliance, and model generalizability require further research. Addressing these gaps will ensure equitable, effective, and scalable AI-driven telemedicine solutions. Future efforts should focus on improving interoperability, standardizing guidelines, and integrating privacy-preserving AI models to facilitate widespread adoption.